GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Formycon AG (XTER:FYB) » Definitions » PB Ratio

Formycon AG (XTER:FYB) PB Ratio : 1.28 (As of Apr. 29, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Formycon AG PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-29), Formycon AG's share price is €39.95. Formycon AG's Book Value per Share for the quarter that ended in Dec. 2023 was €31.15. Hence, Formycon AG's PB Ratio of today is 1.28.

Good Sign:

Formycon AG stock PB Ratio (=1.28) is close to 10-year low of 1.23

The historical rank and industry rank for Formycon AG's PB Ratio or its related term are showing as below:

XTER:FYB' s PB Ratio Range Over the Past 10 Years
Min: 1.23   Med: 9   Max: 21.38
Current: 1.28

During the past 13 years, Formycon AG's highest PB Ratio was 21.38. The lowest was 1.23. And the median was 9.00.

XTER:FYB's PB Ratio is ranked better than
73.21% of 1310 companies
in the Biotechnology industry
Industry Median: 2.375 vs XTER:FYB: 1.28

During the past 12 months, Formycon AG's average Book Value Per Share Growth Rate was 32.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 71.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 55.80% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 28.80% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Formycon AG was 71.70% per year. The lowest was -4.70% per year. And the median was 29.10% per year.

Back to Basics: PB Ratio


Formycon AG PB Ratio Historical Data

The historical data trend for Formycon AG's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Formycon AG PB Ratio Chart

Formycon AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.62 8.57 11.18 3.67 1.80

Formycon AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.18 2.91 3.67 2.33 1.81

Competitive Comparison of Formycon AG's PB Ratio

For the Biotechnology subindustry, Formycon AG's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Formycon AG's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Formycon AG's PB Ratio distribution charts can be found below:

* The bar in red indicates where Formycon AG's PB Ratio falls into.



Formycon AG PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Formycon AG's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=39.95/31.146
=1.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Formycon AG  (XTER:FYB) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Formycon AG PB Ratio Related Terms

Thank you for viewing the detailed overview of Formycon AG's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Formycon AG (XTER:FYB) Business Description

Traded in Other Exchanges
Address
Fraunhoferstrasse 15, Martinsried, Planegg, BY, DEU, 82152
Formycon AG is a pharmaceutical company. It is engaged in the development of pharmaceutical and biopharmaceutical products and the development of drug delivery systems. Its focus is on treatments in ophthalmology and immunology as well as other chronic diseases. The company's pipeline in the biosimilar drugs category includes FYB201, FYB202, FYB203, and FYB207 for the treatment of COVID 19. It is also engaged in the provision of diagnostic laboratory services and works for third parties and the carrying out of diagnostic laboratory services.
Executives
Dr. Stefan Glombitza Board of Directors
Dr. Carsten Brockmeyer Board of Directors
Dr. Nicolas Combé Board of Directors

Formycon AG (XTER:FYB) Headlines

No Headlines